Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of citalopram on brain waves in major depressive disorder
IRCT201203049202N1Phase 4Completed
- Sponsor
- Research Center for Behavioral Disorders and Substance Abuse
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Research Center for Behavioral Disorders and Substance Abuse. Primary endpoint: Changes in brain wave patterns. Started Apr 2012; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201203049202N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201203049202N1.